Myeloid Metaplasia Risk Factors
Investigators at Herlev University, Department of Hematology have published new data on myeloid metaplasia risk factors
Published in Disease Risk Factor Week, January 4th, 2009
A new study, 'Myelofibrosis with myeloid metaplasia: the advanced phase of an untreated disseminated hematological cancer. Time to change our therapeutic attitude with early upfront treatment,' is now available. "Myelofibrosis with myeloid metaplasia (MMM) is the end stage of the Philadelphia-negative chronic myeloproliferative disorders, the classical clinical phenotype being featured by leukoerythroblastic anemia, bone marrow fibrosis and enlargement of the spleen and liver. In the early prefibrotic phase a proportion of the patients may be wrongly classified as having essential thrombocythemia (ET)," researchers in Denmark report.
"Some patients with ET may also...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Disease Risk Factor Week
More Articles from Disease Risk Factor Week
- Abdominal Aortic Aneurysm
Researchers from University of Florence describe findings in abdominal aortic aneurysm - Acromegaly Risk Factors
Findings from University of Brescia broaden understanding of acromegaly risk factors - Addiction Medicine
New study findings reported from R.N. Plotinsky and co-authors - Adenocarcinoma
Study findings from Humanitas Clinical Institute broaden understanding of adenocarcinoma - Adverse Drug Reactions
Allergan, Inc. Announces Nationwide Availability of ACZONE® Gel 5% - Adverse Drug Reactions
Data on adverse drug reactions reported by researchers at University of Louisville - More from this issue of Disease Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
